Patent · US Active

Biochemical markers for acute pulmonary embolism

US8497095B2 · kind B2 · utility

0Cited by

1References

5Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Georg Hess · Mainz, DE
Andrea Horsch · Luzern, CH
Dietmar Zdunek · Tutzing, DE

Key dates

Filing date	Dec 7, 2009
Grant date	Jul 30, 2013
Priority date	—
Expiry date	Mar 11, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/12
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to a method of differentiating between a singular and a multiple lung embolism in a subject suspected to suffer from acute lung embolism comprising determining the amount of NT-proBNP in a sample of a subject suspected to suffer from acute lung embolism and comparing the amount to a reference amount. Further, the present invention also relates to a method of differentiating between acute and chronic lung embolism in a subject comprising determining the amount of NT-proANP at a first and a second time point and comparing the determined amounts with each other. The present invention also encompasses devices and kits for carrying out the aforementioned methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.